NASDAQ | VICL: 0.43  0.00
About Us

Corporate Profile

Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on our patented DNA delivery technologies and other therapeutic approaches.

Headquartered in San Diego, CA, Vical is independently pioneering the development of paradigm-changing therapies, and is partnering with such industry leaders as Astellas, AnGes, Bristol-Myers Squibb, and Merial.


Vical's core technology involves the insertion of DNA into plasmids designed to deliver the desired genes into cells in the body. Vical's logo represents the insertion of DNA technology into a company designed to deliver gene-based products into the market.

P. 858 646 1100 10390 Pacific Center Court, San Diego, California 92121
Designed by Mentus
This link to a non-Vical website is provided as a resource. Vical assumes no responsibility for content not provided by Vical, or for practices or standards of any non-Vical websites.